CollPlant Biotechnologies Ltd. (CLGN)
NCM – Real Time Price. Currency in USD
0.62
-0.04 (-5.93%)
At close: Mar 27, 2026, 4:00 PM EDT
0.60
-0.02 (-3.62%)
After-hours: Mar 27, 2026, 7:55 PM EDT

NCM – Real Time Price. Currency in USD
0.62
-0.04 (-5.93%)
At close: Mar 27, 2026, 4:00 PM EDT
0.60
-0.02 (-3.62%)
After-hours: Mar 27, 2026, 7:55 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.66 | 6.05 | 10 | |
| Quick ratio | 3.45 | 5.63 | 10 | |
| Debt to Equity | 0.32 | 0.30 | 7.0 | |
| Debt to Assets | 0.21 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.2 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 16M | 299K | 11M | 515K | 2M |
| Gross Profit | 14M | -1M | 8M | -2M | 622K |
| Operating Income | 65K | -17M | -8M | -17M | -12M |
| Net Income | 237K | -17M | -7M | -17M | -12M |
| EBITDA | 838K | -16M | -6M | -16M | -11M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 1157.58 | 9.79 | 8.0 |
| Next quarter | -77.62 | -123.08 | 1.0 |
| Current year | 751.65 | 32.41 | 10 |
| Next year | -54.4 | 25.51 | 5.5 |
| Weighted average score | 6.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -56.97 | -4.05 | 3.57 | -28.51 | 1.8 |
| Y/Y | 1825 | 19.49 | 28.95 | 12.62 | 9.3 |
| 3y average | 1123.95 | -2439.8 | -2608.11 | -570.75 | 3.3 |
| 5y average | 738.29 | -1433.4 | -1531.89 | -311.65 | 3.3 |
| Weighted average score | 4.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $8.8M significantly exceed its total debt $2.9M, ensuring strong financial flexibility
Total current assets $9.6M exceed Total current liabilities $2.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.3) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$3.2M limits the company's ability to reinvest or pay down debt